For biotech startups in California, insurance claims do not always go as planned. With new laws shaping how insurers handle coverage decisions, understanding your options is critical for approaching denials effectively. As artificial intelligence plays a larger role in claims, knowing your rights may help clarify what to expect.
What California’s New Law on AI Means for Startups
Senate Bill 1120, sometimes called the “Physicians Make Decisions Act,” took effect on January 1, 2025. The law generally emphasizes the importance of human medical review rather than relying solely on AI to determine coverage. For startups, this means medical professionals will likely review experimental therapies or innovative treatments. While the law does not guarantee approval, it may make the evaluation process more transparent.
Complications That Startups Might Consider When Challenging a Denial
A denied insurance claim may create ripple effects for biotech startups. Before taking action, it could help to consider a few potential challenges such as:
- Financial pressure: Redirecting funds to cover denied costs might slow research or delay new projects.
- Investor concerns: Disputes could lead investors to question the company’s stability or risk management.
- Operational slowdowns: Handling appeals may take time and attention away from core research or production.
- Regulatory overlap: Some denials might involve issues that relate to grant terms or compliance rules.
- Reputation risks: The way a startup responds might shape how partners, insurers, and investors view it.
These complications suggest that a denied claim may benefit from careful attention rather than a rushed response.
Possible Responses to a Denied Claim
If your claim is denied, there are a few actions you may consider. To start, carefully review the denial letter to gain clarity on the insurer’s reasoning. Requesting additional information, such as the credentials of the medical professional who reviewed the claim, could also provide you more insight.
If AI appears to have played a central role in the denial, referencing California’s law and asking for human review might offer additional clarity. You may even have to consider pursuing an appeal, especially if a qualified professional supports covering the treatment. While outcomes are not guaranteed, these steps can help frame a more informed response.
What Other Regulations Should You Keep in Mind?
Startups may also need to be aware of federal rules, such as those enforced by the Committee on Foreign Investment in the United States (CFIUS). These rules might limit your eligibility for federal funding or grants, especially if your technology involves national security, public health or other sensitive areas. Understanding these broader regulations may help anticipate challenges beyond insurance claims.
Staying Informed Can Help
California now limits purely AI-driven claim denials, so staying legally informed could help your startup. If you are contending with insurance challenges, reviewing your claim, requesting human evaluation and keeping clear records are critical first steps. Staying aware of evolving regulations, contracts and federal funding rules can help reduce risks and support your startup’s growth.